메뉴 건너뛰기




Volumn 3, Issue 8, 2015, Pages 595-604

Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: An open-label, randomised controlled trial

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN ASPART; GLUCOSE BLOOD LEVEL; INSULIN;

EID: 84938203857     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00141-2     Document Type: Article
Times cited : (101)

References (23)
  • 2
    • 0035663189 scopus 로고    scopus 로고
    • Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)
    • White NH, Cleary PA, Dahms W, et al. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001, 139:804-812.
    • (2001) J Pediatr , vol.139 , pp. 804-812
    • White, N.H.1    Cleary, P.A.2    Dahms, W.3
  • 3
    • 0036235002 scopus 로고    scopus 로고
    • Findings from the Hvidore Study Group on Childhood Diabetes: metabolic control and quality of life
    • Mortensen HB Findings from the Hvidore Study Group on Childhood Diabetes: metabolic control and quality of life. Horm Res 2002, 57(suppl 1):117-120.
    • (2002) Horm Res , vol.57 , pp. 117-120
    • Mortensen, H.B.1
  • 4
    • 84879274635 scopus 로고    scopus 로고
    • Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines
    • Wood JR, Miller KM, Maahs DM, et al. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care 2013, 36:2035-2037.
    • (2013) Diabetes Care , vol.36 , pp. 2035-2037
    • Wood, J.R.1    Miller, K.M.2    Maahs, D.M.3
  • 5
    • 0031014593 scopus 로고    scopus 로고
    • Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM
    • Davis EA, Keating B, Byrne GC, et al. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care 1997, 20:22-25.
    • (1997) Diabetes Care , vol.20 , pp. 22-25
    • Davis, E.A.1    Keating, B.2    Byrne, G.C.3
  • 6
    • 77952938468 scopus 로고    scopus 로고
    • Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes
    • Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care 2010, 33:1004-1008.
    • (2010) Diabetes Care , vol.33 , pp. 1004-1008
  • 7
    • 65349167348 scopus 로고    scopus 로고
    • Nighttime caregiving behaviors among parents of young children with Type 1 diabetes: associations with illness characteristics and parent functioning
    • Monaghan MC, Hilliard ME, Cogen FR, et al. Nighttime caregiving behaviors among parents of young children with Type 1 diabetes: associations with illness characteristics and parent functioning. Fam Syst Health 2009, 27:28-38.
    • (2009) Fam Syst Health , vol.27 , pp. 28-38
    • Monaghan, M.C.1    Hilliard, M.E.2    Cogen, F.R.3
  • 8
    • 54849147700 scopus 로고    scopus 로고
    • Continuous glucose monitoring and intensive treatment of type 1 diabetes
    • Tamborlane WV, Beck RW, Bode BW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008, 359:1464-1476.
    • (2008) N Engl J Med , vol.359 , pp. 1464-1476
    • Tamborlane, W.V.1    Beck, R.W.2    Bode, B.W.3
  • 9
    • 77954830051 scopus 로고    scopus 로고
    • Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes
    • Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010, 363:311-320.
    • (2010) N Engl J Med , vol.363 , pp. 311-320
    • Bergenstal, R.M.1    Tamborlane, W.V.2    Ahmann, A.3
  • 10
    • 84884610823 scopus 로고    scopus 로고
    • Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial
    • Ly TT, Nicholas JA, Retterath A, et al. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013, 310:1240-1247.
    • (2013) JAMA , vol.310 , pp. 1240-1247
    • Ly, T.T.1    Nicholas, J.A.2    Retterath, A.3
  • 11
    • 79959616082 scopus 로고    scopus 로고
    • Closed-loop insulin delivery: from bench to clinical practice
    • Hovorka R Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol 2011, 7:385-395.
    • (2011) Nat Rev Endocrinol , vol.7 , pp. 385-395
    • Hovorka, R.1
  • 12
    • 84899117172 scopus 로고    scopus 로고
    • Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial
    • Hovorka R, Elleri D, Thabit H, et al. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care 2014, 37:1204-1211.
    • (2014) Diabetes Care , vol.37 , pp. 1204-1211
    • Hovorka, R.1    Elleri, D.2    Thabit, H.3
  • 13
    • 84910135134 scopus 로고    scopus 로고
    • MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial
    • Nimri R, Muller I, Atlas E, et al. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care 2014, 37:3025-3032.
    • (2014) Diabetes Care , vol.37 , pp. 3025-3032
    • Nimri, R.1    Muller, I.2    Atlas, E.3
  • 14
    • 84874368884 scopus 로고    scopus 로고
    • Nocturnal glucose control with an artificial pancreas at a diabetes camp
    • Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013, 368:824-833.
    • (2013) N Engl J Med , vol.368 , pp. 824-833
    • Phillip, M.1    Battelino, T.2    Atlas, E.3
  • 15
    • 84905038018 scopus 로고    scopus 로고
    • Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes cAMP
    • Ly TT, Breton MD, Keith-Hynes P, et al. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes cAMP. Diabetes Care 2014, 37:2310-2316.
    • (2014) Diabetes Care , vol.37 , pp. 2310-2316
    • Ly, T.T.1    Breton, M.D.2    Keith-Hynes, P.3
  • 16
    • 77956071742 scopus 로고    scopus 로고
    • Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes
    • Castle JR, Engle JM, El Youssef J, et al. Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care 2010, 33:1282-1287.
    • (2010) Diabetes Care , vol.33 , pp. 1282-1287
    • Castle, J.R.1    Engle, J.M.2    El Youssef, J.3
  • 17
    • 84875188726 scopus 로고    scopus 로고
    • Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial
    • Haidar A, Legault L, Dallaire M, et al. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. CMAJ 2013, 185:297-305.
    • (2013) CMAJ , vol.185 , pp. 297-305
    • Haidar, A.1    Legault, L.2    Dallaire, M.3
  • 18
    • 84904574791 scopus 로고    scopus 로고
    • Outpatient glycemic control with a bionic pancreas in type 1 diabetes
    • Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014, 371:313-325.
    • (2014) N Engl J Med , vol.371 , pp. 313-325
    • Russell, S.J.1    El-Khatib, F.H.2    Sinha, M.3
  • 19
    • 84926287781 scopus 로고    scopus 로고
    • Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial
    • Haidar A, Legault L, Messier V, et al. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Lancet Diabetes Endocrinol 2015, 1:17-26.
    • (2015) Lancet Diabetes Endocrinol , vol.1 , pp. 17-26
    • Haidar, A.1    Legault, L.2    Messier, V.3
  • 20
    • 84920645672 scopus 로고    scopus 로고
    • Association between post-dinner dietary intakes and nocturnal hypoglycemic risk in adult patients with type 1 diabetes
    • Desjardins K, Brazeau AS, Strychar I, et al. Association between post-dinner dietary intakes and nocturnal hypoglycemic risk in adult patients with type 1 diabetes. Diabetes Res Clin Pract 2014, 106:420-427.
    • (2014) Diabetes Res Clin Pract , vol.106 , pp. 420-427
    • Desjardins, K.1    Brazeau, A.S.2    Strychar, I.3
  • 22
    • 84896390985 scopus 로고    scopus 로고
    • Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis
    • Nimri R, Muller I, Atlas E, et al. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis. Pediatr Diabetes 2014, 15:91-99.
    • (2014) Pediatr Diabetes , vol.15 , pp. 91-99
    • Nimri, R.1    Muller, I.2    Atlas, E.3
  • 23
    • 84908316913 scopus 로고    scopus 로고
    • Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study
    • Thabit H, Lubina-Solomon A, Stadler M, et al. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study. Lancet Diabetes Endocrinol 2014, 2:701-709.
    • (2014) Lancet Diabetes Endocrinol , vol.2 , pp. 701-709
    • Thabit, H.1    Lubina-Solomon, A.2    Stadler, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.